. 2020 Aug 25;9(9):1959. doi: 10.3390/cells9091959

Table 1.

Patient information.

For Label-Free Proteomics	AD
For Label-Free Proteomics	(n = 3)
Age, mean	82.7 ± 7.57
Gender	2M, 1F
For TMT-Label Proteomics	CTRL	MCI	AD	t-test ^a (p-value ^b)	t-test ^a (p-value ^b)	t-test ^a (p-value ^b)
For TMT-Label Proteomics	(n = 10)	(n = 10)	(n = 10)	(CTRL_MCI)	(CTRL_AD)	(MCI_AD)
Age, mean	89.8 ± 6.12	89.0 ± 5.27	87.1 ± 4.41	0.313 (0.758)	1.131 (0.273)	0.874 (0.393)
Gender ^c	5M, 5F	5M, 5F	5M, 5F
PMI, mean	2.90 ± 0.85	2.94 ± 0.87	2.84 ± 0.49	−0.106 (0.917)	0.173 (0.865)	0.299 (0.768)
Braak stage	2.8 ± 0.42	3.3 ± 0.67	5.4 ± 0.52	−1.987 (0.062)	−12.333 (<0.001)	−7.814 (<0.001)

^a The group comparisons were performed using independent t-test. ^b The statistical significance of the differences were calculated using a two-tailed test. ^c M: Male, F: Female.